📰 Meyer Children News
Meyer Children News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Meyer Children. Real-time updates on events, politics, business and more.
June 26, 2023
CAMZYOS is the first and only cardiac myosin inhibitor approved in the European Union Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALOR-HCM, demonstrating significant benefit in patients treated with CAMZYOS versus placebo
May 30, 2023
The International School of Florence held its annual philanthropic gala on May 12 at Stazione Leopolda.
November 4, 2022
A FAMILY is currently fundraising to send their child abroad for a “better chance of life”.
June 9, 2022
A single therapeutic dose administered on the first day of a drug provocation test could be safe in diagnosing mild nonimmediate reactions to amoxicillin-clavulanic acid, according to a study published in Pediatric Allergy and Immunology. This single dose would save time because patients would spend less time in the hospital, Giulia Liccioli, MD, of the allergy unit in the department of
May 10, 2022
FLORENCE, Italy, May 10, 2022 /PRNewswire/ -- Baebies®, a growth-stage medical device company developing innovative products to enable early disease d...
June 4, 2021
Mohamed* was just 14 years old when he left Somalia, entrusting his life to traffickers in hopes of reaching Europe. In Libya, he was tortured and almost died from tuberculosis. Thanks to a humanitarian corridor, the 17-year-old was able to transfer to Italy and receive ...